|
Oct 4
|
KalVista Pharmaceuticals Presents Sebetralstat Data at the 2024 HAEi Global Angioedema Forum
|
|
Oct 2
|
High Growth Tech Stocks To Watch In The United States
|
|
Sep 30
|
KalVista Announces the Submission of Additional Marketing Authorization Applications for Sebetralstat for the Oral On-Demand Treatment of Hereditary Angioedema
|
|
Sep 26
|
KalVista Pharmaceuticals Announces Nine Abstracts Accepted for Presentation at the HAEi Global Angioedema Forum (GAF)
|
|
Aug 29
|
KalVista Pharmaceuticals Announces Six Abstracts Accepted for Presentation at the 2024 Bradykinin Symposium
|
|
Jun 18
|
KalVista Submits New Drug Application to FDA for Sebetralstat as First Oral On-demand Treatment for Hereditary Angioedema
|
|
May 1
|
KalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal Year
|
|
Apr 22
|
KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors
|
|
Apr 5
|
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
|
|
Apr 3
|
KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 18
|
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas
|
|
Mar 12
|
KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat
|
|
Mar 11
|
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
|
|
Mar 8
|
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas
|
|
Mar 7
|
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer
|
|
Mar 6
|
KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference
|
|
Jan 13
|
Insider Sell: Chief Scientific Officer Edward Feener Sells 22,679 Shares of KalVista ...
|
|
Jan 12
|
Insider Sell: Chief Scientific Officer Edward Feener Sells 17,321 Shares of KalVista ...
|
|
Dec 30
|
Insider Sell: CEO Thomas Crockett Sells 30,000 Shares of KalVista Pharmaceuticals Inc (KALV)
|
|
Dec 29
|
16 Most Promising Long-Term Stocks According to Analysts
|